FDA label

What is Ryaltris used for?

Ryaltris contains olopatadine and mometasone furoate. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.

Source: DailyMed SPL label file dated 2026-10-23. Publisher page

The FDA label says: “RYALTRIS is indicated for the treatment of symptoms of seasonal allergic rhinitis in adult and pediatric patients of age 6 years and older.”

Run it in Rivvi

Which 2027 plans near you dropped or restricted Ryaltris?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Ryaltris, spray, metered

Indications and Usage, quoted from the label by Glenmark Pharmaceuticals Inc., USA (NDA211746). Cross-references to other label sections are left out.

RYALTRIS is indicated for the treatment of symptoms of seasonal allergic rhinitis in adult and pediatric patients of age 6 years and older.

Source: DailyMed label, set id 406be932-f00e-4c66-9dd1-c142090fe822, version 2, effective July 21, 2026. NDC 68462-659, one of 2 listings for this product.

Questions

What is Ryaltris used for?

The FDA label says: “RYALTRIS is indicated for the treatment of symptoms of seasonal allergic rhinitis in adult and pediatric patients of age 6 years and older.”

What drug class is Ryaltris?

FDA lists olopatadine and mometasone furoate in the Corticosteroid and Histamine-1 Receptor Antagonist and Histamine-1 Receptor Inhibitor and Mast Cell Stabilizer established pharmacologic class.

Does this page cover off-label uses or dosing?

No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.

More on Ryaltris

Try it on your own data today.

Free to start. Most teams are using it the same day.